• All
  • Important
  • Financial Update
  • Fund Raise
  • Board Meeting
  • Dividend/Bonus
  • JV/Acquisition
  • Investor Meet
  • Insider Trade
  • Pledging
  • Others
    ALPHA TRIBE

    Par Drugs and Chemicals Limited — Board Meeting, 22-08-2026: Outcome of Board Meeting

    22-08-2026 | 06:06 pm

    Par Drugs' board met. Approved FY26 annual results: Revenue ₹103.66 Cr, PAT ₹13.11 Cr. Key approvals include higher remuneration for MD, CEO (₹0.64 Cr each), & Ind. Director (₹0.24 Cr), all subject to shareholder vote. MD/CEO now authorized for investment management.

    No comments yet. Be the first to comment!

    All announcements from Par Drugs and Chemicals Limited